CARsgen Appoints Dr. Hong MA as Senior Vice President of Clinical Development
Aug 27, 2018
SHANGHAI,?Aug. 27, 2018?/PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, announced appointment of?Dr. Hong Ma?as Senior Vice President, Clinical Development. Dr. Ma will be responsible for CARsgen clinical strategy, leading clinical development and medical team overseas.